Editorial - Direct-acting antivirals therapy in HCV patients with HCC: lights and shadow

被引：0
|
作者：
Rinaldi, B. [1 ]
Rosato, V. [2 ]
Galiero, R. [3 ]
Vetrano, E. [3 ]
Fasano, M. [4 ]
Rinaldi, L. [3 ]
机构：
[1] Univ Campania Luigi Vanvitelli, Sect Pharmacol, Dept Expt Med, Naples, Italy
[2] Osped Evangelico Betania, Liver Unit, Naples, Italy
[3] Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Naples, Italy
[4] Univ Campania Luigi Vanvitelli, Dept Precis Med, Naples, Italy
来源：
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2021年 / 25卷 / 24期
关键词：
ADVANCED HEPATOCELLULAR-CARCINOMA; HEPATITIS-C; IMPACT;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：7622 / 7625
页数：4
相关论文
共 50 条
  • [1] Editorial - HCC in HCV patients and the direct acting antivirals: is there really a link?
    Marrone, A.
    Franci, G.
    Perrella, A.
    Nevola, R.
    Chianese, A.
    Adinolfi, L. E.
    Sasso, F. C.
    Rinaldi, L.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (02) : 983 - 987
  • [2] Impact of HCV Therapy with Direct-Acting Antivirals on Lipid Profiles
    Dharwadkar, Pooja
    Drechsler, Henning
    Kouma, Marcus
    Brown, Geri
    Bedimo, Roger
    [J]. HEPATOLOGY, 2016, 64 : 980A - 980A
  • [3] Fibrosis improvement in patients with HCV treated with direct-acting antivirals
    McPhail, James
    Sims, Omar T.
    Guo, Yuqi
    Wooten, David
    Herndon, John S.
    Massoud, Omar I.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (07) : 996 - 1000
  • [4] Comparative effectiveness of direct-acting antivirals for HCV
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (09): : 698 - 698
  • [5] Early occurrence of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis treated with direct-acting antivirals (DAAs)
    Calvaruso, V.
    Cabibbo, G.
    Cacciola, I.
    Petta, S.
    Madonia, S.
    Bellia, A.
    Tine, F.
    Distefano, M.
    Giannitrapani, L.
    Prestileo, T.
    Mazzola, G.
    Davi, A.
    Larocca, L.
    Ardiri, A.
    Digiacomo, A.
    Gussio, M.
    Guarneri, L.
    Magro, A.
    Averna, A.
    Iacobello, C.
    Scalisi, I.
    Cartabellotta, F.
    Savalli, F.
    Russello, M.
    Scifo, G.
    Squadrito, G.
    Camma, C.
    Raimondo, G.
    Craxi, A.
    Di Marco, V.
    [J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E60 - E60
  • [6] Uptake of HCV Therapy in HIV/HCV Coinfected Patients across Europe in the Era of Direct-Acting Antivirals
    Peters, Lars
    [J]. HEPATOLOGY, 2016, 64 : 969A - 969A
  • [7] Stratification of Residual Risk of HCC Following HCV Clearance With Direct-Acting Antivirals in Patients With Advanced Fibrosis and Cirrhosis
    Setiawan, V. Wendy
    Rosen, Hugo R.
    [J]. HEPATOLOGY, 2020, 72 (06) : 1897 - 1899
  • [8] Eradication of HCV induced by direct-acting antivirals is associated with a 79% reduction in HCC risk.
    Ioannou, George N.
    Green, Pamela
    Berry, Kristin
    [J]. HEPATOLOGY, 2017, 66 : 82A - 83A
  • [9] Direct-acting antivirals for paediatric HCV: we got there
    Sokal, Etienne M.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (08) : 452 - +
  • [10] Mortality associated with the treatment of HCV with direct-acting antivirals
    Laurain, Anne
    Kramer, Laura
    Sultanik, Philippe
    Vallet-Pichard, Anais
    Sogni, Philippe
    Pol, Stanislas
    [J]. GUT, 2018, 67 (01) : 197 - +
12345